Literature DB >> 10945376

Drug-induced respiratory disorders: incidence, prevention and management.

L Ben-Noun1.   

Abstract

Various drugs are associated with adverse respiratory disorders (ARDs) ranging in severity from mild, moderate to severe and even fatal. Cardioselective and nonselective beta-blockers, calcium antagonists and dipyridamole can induce asthma. ACE inhibitors are mainly associated with cough. Amiodarone is related to a form of interstitial pneumonitis (IP) which can be fatal, tocainidine and flecainidine to a form of IP, and hydrochlorothiazide to a form of IP and pulmonary oedema. Antiasthmatic drugs can be associated with a paradoxical bronchospasm, while leukotriene antagonists are linked to the development of Churg-Strauss syndrome. Nonsteroidal anti-inflammatory drugs including aspirin (acetylsalicylic acid) may induce asthma. Gold is mainly related to IP, penicillamine to IP, systemic lupus erythematosus, bronchiolitis obliterans, and Goodpasture's syndrome. Acute respiratory reactions to nitrofurantoin include dyspnoea, cough, IP, and pleural effusion while IP and fibrosis are common in chronic reactions. Other antibacterials mainly evoke pneumonitis, pulmonary infiltrates and eosinophilia, and bronchiolitis obliterans. ARDs are similar for most categories of cytotoxic agents, with chronic pneumonitis and fibrosis being the most common. Noncardiogenic pulmonary oedema occurs as the most common respiratory complication in opioid agonist addiction. Psychotropic drugs such as phenothiazides, butyrophenones and tricyclic antidepressants can also induce pulmonary oedema. Oral contraceptives may produce asthma exacerbation, while long term use and/or high doses of postmenopausal hormone replacement therapy increase the risk of asthma. Bromocriptine is mainly associated with pleural effusion, while methysergide is usually associated with pleural effusion and fibrosis. Some anorectic agents have been linked to the development of primary pulmonary hypertension. The possibility of the occurrence of ARDs should be taken into account in each individual patient. Although in most cases the adverse effects are unpredictable, they can be reduced to a minimum or prevented if some drugs are avoided or stopped in time.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945376     DOI: 10.2165/00002018-200023020-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  239 in total

1.  Bleomycin-related lung damage: CT evidence.

Authors:  E A Bellamy; J E Husband; R M Blaquiere; M R Law
Journal:  Radiology       Date:  1985-07       Impact factor: 11.105

2.  Bronchoconstriction in response to ipratropium bromide.

Authors:  K R Patel; W M Tullett
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

Review 3.  Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Authors:  Z H Israili; W D Hall
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

4.  Effect of propranolol on the airway response to prostaglandin E2 in normal man.

Authors:  R V Seth; V S Clarke; R A Lewis; A E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

5.  Adverse reactions to cromolyn.

Authors:  G A Settipane; D E Klein; G K Boyd; J H Sturam; H B Freye; J K Weltman
Journal:  JAMA       Date:  1979-02-23       Impact factor: 56.272

6.  Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities.

Authors:  E S Overland; A J Nolan; P C Hopewell
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965

7.  Pulmonary edema after freebase cocaine smoking--not due to an adulterant.

Authors:  J N Kline; J D Hirasuna
Journal:  Chest       Date:  1990-04       Impact factor: 9.410

8.  Tolerability and efficacy of antihypertensive treatment with cilazapril in general practice.

Authors:  J R Rosenthal; U Osowski
Journal:  Cardiology       Date:  1996 Jan-Feb       Impact factor: 1.869

9.  Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976.

Authors:  L Holmberg; G Boman
Journal:  Eur J Respir Dis       Date:  1981-06

Review 10.  Lung disorders due to drug abuse.

Authors:  K A McCarroll; M H Roszler
Journal:  J Thorac Imaging       Date:  1991-01       Impact factor: 3.000

View more
  10 in total

1.  In vitro exposure of precision-cut lung slices to 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride (NSC 710305, Phortress) increases inflammatory cytokine content and tissue damage.

Authors:  Holger P Behrsing; Michael J Furniss; Myrtle Davis; Joseph E Tomaszewski; Ralph E Parchment
Journal:  Toxicol Sci       Date:  2012-11-09       Impact factor: 4.849

Review 2.  Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

3.  [Pulmonary infiltrates with blood eosinophilia in a 62-year-old patient].

Authors:  M Kohlhäufl; N Weber; A Morresi-Hauf; D Geiger; H Raith; K Häussinger
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

4.  Acute lung injury during antithymocyte globulin therapy for aplastic anemia.

Authors:  Ewan Christopher Goligher; Christine Cserti-Gazdewich; Meyer Balter; Vikas Gupta; Joseph E Brandwein
Journal:  Can Respir J       Date:  2009 Mar-Apr       Impact factor: 2.409

5.  Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study.

Authors:  Meng-Ting Wang; Chen Wei Lin; Chen-Liang Tsai; Yun-Han Wang; Jyun-Heng Lai; Chin-Bin Yeh; Ya-Ling Huang; Yu-Juei Hsu
Journal:  Br J Clin Pharmacol       Date:  2020-05-30       Impact factor: 4.335

6.  Investigating a case of recurrent pleural effusion.

Authors:  Patrícia Rodrigues; Maria Neves; João Pedro Ferreira; Miguel Araújo Abreu; Fernanda Almeida
Journal:  Case Rep Pulmonol       Date:  2011-10-15

7.  Zofenopril and incidence of cough: a review of published and unpublished data.

Authors:  Stefano Omboni; Claudio Borghi
Journal:  Ther Clin Risk Manag       Date:  2011-11-29       Impact factor: 2.423

Review 8.  HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review.

Authors:  Giulio Distefano; Luigi Fanzone; Monica Palermo; Francesco Tiralongo; Salvatore Cosentino; Corrado Inì; Federica Galioto; Ada Vancheri; Sebastiano E Torrisi; Letizia A Mauro; Pietro V Foti; Carlo Vancheri; Stefano Palmucci; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2020-04-22

9.  Comment on "Pulmonary Function Tests in Hypertensive Patients Attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia".

Authors:  Yusuf Ziya Şener; Vedat Hekimsoy; Metin Okşul
Journal:  Int J Hypertens       Date:  2019-04-04       Impact factor: 2.420

10.  Post-hospital syndrome in adults with asthma: a case-crossover study.

Authors:  Mohsen Sadatsafavi; Larry D Lynd; J Mark Fitzgerald
Journal:  Allergy Asthma Clin Immunol       Date:  2013-12-23       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.